No abstract available
Keywords:
COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination.
MeSH terms
-
Antibodies, Neutralizing / blood
-
Antibodies, Neutralizing / immunology
-
Antibodies, Viral / blood
-
Antibodies, Viral / immunology
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / immunology*
-
BNT162 Vaccine
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines / immunology*
-
Heterocyclic Compounds, 3-Ring / therapeutic use
-
Humans
-
Immunization, Secondary
-
Immunocompromised Host / immunology*
-
Immunogenicity, Vaccine / drug effects
-
Immunogenicity, Vaccine / immunology
-
Male
-
Methotrexate / therapeutic use
-
Middle Aged
-
Polycythemia Vera / complications
-
SARS-CoV-2
-
Vasculitis, Leukocytoclastic, Cutaneous / complications
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
Antirheumatic Agents
-
COVID-19 Vaccines
-
Heterocyclic Compounds, 3-Ring
-
upadacitinib
-
BNT162 Vaccine
-
Methotrexate
Supplementary concepts
-
COVID-19 vaccine booster shot